- Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
- Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
- Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
- Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
- Generation Bio to Present at the 2024 TD Cowen Health Care Conference
- Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms
- Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results
- Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform
More ▼
Key statistics
On Friday, Generation Bio Co (GBIO:NSQ) closed at 3.26, 279.07% above the 52 week low of 0.86 set on Oct 25, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.26 |
---|---|
High | 3.35 |
Low | 3.21 |
Bid | 2.90 |
Offer | 3.60 |
Previous close | 3.32 |
Average volume | 111.62k |
---|---|
Shares outstanding | 66.53m |
Free float | 56.80m |
P/E (TTM) | -- |
Market cap | 207.57m USD |
EPS (TTM) | -2.56 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 21:00 BST.
More ▼